Concepedia

Christopher P. Loo

CP

Statistics

Publications

21

Citations

1.1K

H-Index

16

Active since

2003

Affiliations

University of California, San Francisco(Current)

Karolinska Institutet

San Francisco General Hospital

Karolinska University Hospital

Universidade Federal de São Paulo

Christopher P. Loo is an author at University of California, San Francisco specializing in immunology, life sciences, and infectious diseases.

ORCID

Publications per year

2003–2024

21

Publications

21

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin

Ryan S. Lane, Julia Femel, Alec P. Breazeale et al. · The Journal of Experimental Medicine · 2018 · 161 citations · Full text

, , +17

Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal

Fatema A. Legrand, Douglas F. Nixon, Christopher P. Loo et al. · PLoS ONE · 2006 · 144 citations · Full text

, , +17

Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8<sup>+</sup>T<sub>EMRA</sub>Cells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point

John Northfield, Christopher P. Loo, Jason D. Barbour et al. · Journal of Virology · 2007 · 97 citations · Full text

, , +17

Exploring Sponge-Derived Terpenoids for Their Potency and Selectivity against 12-Human, 15-Human, and 15-Soybean Lipoxygenases

Taro Amagata, Stephanie Whitman, Tyler A. Johnson et al. · Journal of Natural Products · 2003 · 93 citations · Full text

, , +17

Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection

Christopher P. Loo, Nicholas A. Nelson, Ryan S. Lane et al. · Cell Reports · 2017 · 79 citations · Full text

, , +17

1–5 of 21